Dr Reddys Laboratories RDY
NYSE RDY
$15.02 +0.11 (+0.77%)
As of: Nov 9, 2026 · 2:43 PM EST

Dr Reddys Laboratories (RDY) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

Dr Reddys Laboratories (RDY) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,261.91 Bn 1,235.52 Bn 20.46 Bn -
2 Johnson & Johnson 679.68 Bn 599.54 Bn 17.30 Bn 308.00 Mn
3 AbbVie 518.95 Bn 486.95 Bn 13.12 Bn -
4 Merck 366.60 Bn 329.54 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 317.41 Bn 290.65 Bn - 88.00 Mn
6 Astrazeneca 293.70 Bn 267.59 Bn 13.26 Bn -
7 Amgen 251.07 Bn 202.73 Bn 7.58 Bn -
8 Gilead Sciences 210.48 Bn 185.59 Bn 6.73 Bn -
9 Pfizer 168.15 Bn 115.51 Bn 12.56 Bn 2.53 Bn
10 Dr Reddys Laboratories 12.49 Bn 11.84 Bn 472.93 Mn 103.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 103.06 Mn
Jun 30, 2026 166.30 Mn
Sep 30, 2025 66.75 Mn
Jun 30, 2025 27.58 Mn
Sep 30, 2024 1.38 Bn
Jun 30, 2024 566.61 Mn
Mar 31, 2024 -831.76 Mn
Dec 31, 2023 278.67 Mn
Sep 30, 2023 467.56 Mn
Jun 30, 2023 403.66 Mn
Mar 31, 2023 440.26 Mn
Dec 31, 2022 209.73 Mn
Sep 30, 2022 360.64 Mn
Jun 30, 2022 397.38 Mn
Mar 31, 2022 401.47 Mn
Dec 31, 2021 161.35 Mn
Sep 30, 2021 263.67 Mn
Jun 30, 2021 216.41 Mn
Mar 31, 2021 138.75 Mn
Dec 31, 2020 218.19 Mn
API Access

Dr Reddys Laboratories Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RDY&period=max&api_key=YOUR_API_KEY